Complexes of Cysteine and Cysteinemethylester with Pd(II) and Pt(II)

Synthesis, Characterization, and Non-Covalent Interactions of Palladium(II)-Amino Acid Complexes

The reaction of palladium(II) acetate with acyclic amino acids in acetone/water yields square planar bis-chelated palladium amino acid complexes that exhibit interesting non-covalent interactions. In all cases, complexes were examined by multiple spectroscopic techniques, especially HRMS (high resolution mass spectrometry), IR (infrared spectroscopy), and ¹H NMR (nuclear magnetic resonance) spectroscopy. In some cases, suitable crystals for single crystal X-ray diffraction were able to be grown and the molecular structure was obtained. The molecular geometries of the products are discussed. Except for the alanine complex, all complexes incorporate water molecules into the extended lattice and exhibit N-H···O and/or O···(HOH)···O hydrogen bonding interactions. The non-covalent interactions are discussed in terms of the extended lattice structures exhibited by the structures.

Fate of cisplatin and its main hydrolysed forms in the presence of thiolates: a comprehensive computational and experimental study

Thiolations and bidentations drive the chemical fate of cisplatin compounds in intracellular medium.

Labile Pd-sulphur and Pt-sulphur bonds in organometallic palladium and platinum complexes [(COD)M(alkyl)(S-ligand)]n+-A speciation study

Reaction of various sulphur ligands L (SEt^-, SPh^-, SC₆F₄H-4^-, SEt₂, StBu₂, SnBu₂, DMSO, DPSO) with the precursors [(COD)M(R)Cl] (COD=1,5-cyclooctadiene, M=Pd or Pt; R=methyl (Me) or benzyl (Bn); DMSO=dimethyl sulfoxide; DPSO=diphenyl sulfoxide) allowed isolation and characterisation of mononuclear neutral (n=0) or cationic (n=1) complexes [(COD)Pt(R)(L)]ⁿ⁺. Reaction of l-cysteine (HCys) with [(COD)Pt(Me)Cl] under similar conditions gave the binuclear cationic complex in [{(COD)Pt(Me)}₂(μ-Cys)]Cl. Detailed NMR spectroscopy and single crystal X-ray diffraction in the case of [(COD)Pt(Me)(SEt₂)][SbF₆] and [(COD)Pt(Me)(DMSO)][SbF₆] reveal markedly labilised Pt-S bonds as a consequence of the highly covalent Pt-C bonds of the R coligands in these organometallic species. Cationic charge (n=1) seems to lower the Pt-S bond strength further. Consequently, most of these complexes are not stable long-term in aqueous DMF (N,N-dimethylformamide) solutions. This made the evaluation of their antiproliferative properties towards HT-29 colon carcinoma and MCF-7 breast adenocarcinoma cell lines impossible. Only the two complexes [(COD)Pt(R)(SC₆F₄H-4)] with R=Me or SC₆F₄H-4 coligands could be tested with the R=Me complex showing promising activity (in the range of cisplatin), while the R=SC₆F₄H-4 derivative is largely inactive, as were the phosphane complexes [(dppe)Pt(SC₆F₄H-4)₂] (dppe=1,2-bis(diphenylphosphino)ethane), cis-[(PPh₃)₂Pt(SC₆F₄H-4)₂] and cis-[(PPh₃)₂PtCl₂] which were tested for comparison. In turn, our findings might pave the way to new Pt anti-cancer drugs with largely reduced unwanted depletion of incorporated drugs and reduced side-effects from binding to S-containing biomolecules.

Kinetic and Mechanistic Aspects of Ligand Substitution on cis- Diaqua (cis-1,2-Diaminocyclohexane)Platinum(II) with Three Glycine-Containing Dipeptides

The kinetics of the interaction of glycyl-L-valine(L1-L′H), glycyl-L-isoleucine (L2-L′H) and glycyl-L-glutamine(L3-L′H) with cis-[Pt( cis-dach)(OH2)2]2+ (dach = 1,2-diaminocyclohexane) have been studied spectrophotometrically as a function of [ cis-[Pt( cis-dach)(OH2)2]2+], [ligand], pH and temperature at constant ionic strength, where the complex exists predominantly as the diaqua species and the dipeptides as a zwitterion. The substitution reactions show two consecutive steps: the initial is the ligand-assisted anation and the subsequent step is chelation. The activation parameters for both steps were evaluated using Eyring's equation. The low DL H1 ≠ and large negative value of Δ S1 ≠ as well as Δ H2 ≠ and Δ S2 ≠ indicate an associative mode of activation for both the aqua ligand substitution processes. The products of the reactions have been characterised using IR and ESI-mass spectroscopic analysis. The title complex is already established as an anticancer drug; but its reactivity with all biomolecules will confirm its therapeutic activity (i.e. its efficacy versus toxicity).

Interaction of Glycyl – Glycine with Hydroxopentaaquarhodium(Iii) Ion in Aqueous Medium: Kinetic and Mechanistic Studies

The kinetics of interaction between glycyl-glycine (L-L'H) and[Formula: see text] [Rh(H2O)5OH] 2+ have been studied spectrophotometrically in aqueous medium as a function of [Rh(H2O)5OH] 2+], [glycyl - glycine], pH and temperature at constant ionic strength. At pH 4.3, the interaction with glycyl-glycine shows two parallel paths: both processes are ligand-dependent. The rate constant for the processes are: k1 ∼ 10 −3 s −1 and k2∼10−5 s−3. The activation parameters calculated from Eyring plots are: ΔH1≠ - 26.7 ± 0.3 kj mol−1, ΔS1≠ =-207+1 JK−1 mol−1, ΔH2≠ = 92.4 ± 1.3 kJ mol−1 and ΔS2≠ = −42±4 JK−1 mol−1. The ligand glycyl-glycine, with different donor atoms (N and O), attacks two rhodium(III) ions (Rh(III) being a borderline acid), with different reactivity. Based on the kinetic and activation parameters, an associative interchange mechanism is proposed for both interaction processes. From the temperature dependence of the outer-sphere association equilibrium constant, the thermodynamic parameters calculated are: ΔH1∘ = 21.8 ± 1.9 kJ mol−1, ΔS1∘ = 124± 6 JK−1 mol−1, ΔH2∘ = 12.7 ±0.5 kj mol−1 and ΔS2∘ 89±2 JK−1 mol″−1 which give a negative A G° value for both the steps at all temperatures studied, supporting the spontaneous formation of an outer- sphere association complex for both the parallel paths. The product of the reaction has been characterized from IR and ESI-mass spectroscopic analysis.

Interaction of the antitumor agents cis,cis,trans-Pt(IV)(NH3)2Cl2(OH)2 and cis,cis,trans-Pt(IV)[(CH3)2CHNH2]2Cl2(OH)2 and their reduction products with PM2 DNA

The ability of two platinum(IV) antitumor agents, cis,cis,trans-PtIV[(CH3)2CHNH2]2Cl2(OH)2 (2) and cis,cis,trans-PtIV(NH3)2Cl2(OH)2 (4), to interact with PM2 DNA was examined. Analysis using gel electrophoresis showed that neither compound is able to alter the electrophoretic mobilities of the three forms of PM2 DNA in the gel. However, incubation of 2 and 4 with 2 equiv of Fe(ClO4)2 X 6H2O or 1 equiv of ascorbic acid results in reduction to yield the divalent complexes cis-PtII(NH3)2Cl2 (1) and cis-PtII-[(CH3)2CHNH2]2Cl2 (3). The structures of the reduction products were characterized by using elemental analysis as well as infrared and 195Pt NMR spectroscopies. Both 1 and 3 were found to bind to and unwind supercoiled form I PM2 DNA. The aforementioned observations support the suggestion that reduction is a means of activating the antitumor properties of 2 and 4.